Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05592626
Title A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors (START-001)
Acronym START-001
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Marengo Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | CAN

Facility Status City State Zip Country Details
AdventHealth Celebration RECRUITING Celebration Florida 34747 United States Details
University of Miami Sylvester Comprehensive Cancer Center RECRUITING Miami Florida 33136 United States Details
National Institutes of Health RECRUITING Bethesda Maryland 20892 United States Details
Massachusetts General Hospital Cancer Center RECRUITING Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Memorial Sloan-Kettering Cancer Center RECRUITING New York New York 10065 United States Details
The Ohio State University Comprehensive Cancer Center RECRUITING Columbus Ohio 43210 United States Details
Princess Margaret Cancer Centre RECRUITING Toronto Ontario M5G 2C4 Canada Details
Institute Gustave Roussy RECRUITING Villejuif 94800 France Details
Vall d'Hebron Institute of Oncology RECRUITING Barcelona Cataluna 08035 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field